You are here

  • Home
  • Archive
  • Volume 12, Issue 11
  • Reirradiation Options for Previously Irradiated Prostate cancer (RO-PIP): Feasibility study investigating toxicity outcomes following reirradiation with stereotactic body radiotherapy (SBRT) versus high-dose-rate brachytherapy (HDR-BT)

Citation Tools

Article menu

Download PDFPDF

Oncology
Protocol
Reirradiation Options for Previously Irradiated Prostate cancer (RO-PIP): Feasibility study investigating toxicity outcomes following reirradiation with stereotactic body radiotherapy (SBRT) versus high-dose-rate brachytherapy (HDR-BT)

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Zhong J, Brown S, Serra M, et al
Reirradiation Options for Previously Irradiated Prostate cancer (RO-PIP): Feasibility study investigating toxicity outcomes following reirradiation with stereotactic body radiotherapy (SBRT) versus high-dose-rate brachytherapy (HDR-BT)
BMJ Open 2022;12:e068580. doi: 10.1136/bmjopen-2022-068580